Cystitis

Bifidobacterium breve – BR03 (DSM 16604)

Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction […]

Bifidobacterium breve – BR03 (DSM 16604) Read More »

Scroll to Top
Browse companies by type
Brought to you by